0001140361-17-032509.txt : 20170816
0001140361-17-032509.hdr.sgml : 20170816
20170816213225
ACCESSION NUMBER: 0001140361-17-032509
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170814
FILED AS OF DATE: 20170816
DATE AS OF CHANGE: 20170816
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: AYERS JONATHAN W
CENTRAL INDEX KEY: 0001184149
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19271
FILM NUMBER: 171037558
MAIL ADDRESS:
STREET 1: IDEXX LABORATORIES, INC.
STREET 2: ONE IDEXX DRIVE
CITY: WESTBROOK
STATE: ME
ZIP: 04092
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: IDEXX LABORATORIES INC /DE
CENTRAL INDEX KEY: 0000874716
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
IRS NUMBER: 010393723
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE IDEXX DRIVE
CITY: WESTBROOK
STATE: ME
ZIP: 04092-2041
BUSINESS PHONE: 2075560300
MAIL ADDRESS:
STREET 1: ONE IDEXX DRIVE
CITY: WESTBROOK
STATE: ME
ZIP: 04092-2041
FORMER COMPANY:
FORMER CONFORMED NAME: IDEXX CORP / DE
DATE OF NAME CHANGE: 19600201
4
1
doc1.xml
FORM 4
X0306
4
2017-08-14
0
0000874716
IDEXX LABORATORIES INC /DE
IDXX
0001184149
AYERS JONATHAN W
ONE IDEXX DRIVE
WESTBROOK
ME
04092
1
1
0
0
Chairman, President & CEO
Common Stock
2017-08-14
4
M
0
18000
38.795
A
1043034
D
Common Stock
2017-08-14
4
S
0
18000
154.9076
D
1025034
D
Common Stock
2017-08-14
4
M
0
2000
38.795
A
1027034
D
Common Stock
2017-08-15
4
M
0
14900
38.795
A
1041934
D
Common Stock
2017-08-15
4
S
0
14900
154.7146
D
1027034
D
Common Stock
2017-08-15
4
M
0
5100
38.795
A
1032134
D
Common Stock
2017-08-15
4
S
0
5100
154.3334
D
1027034
D
Common Stock
2017-08-15
4
M
0
2000
38.795
A
1029034
D
Common Stock
2017-08-16
4
M
0
20000
38.795
A
1049034
D
Common Stock
2017-08-16
4
S
0
20000
155.4744
D
1029034
D
Common Stock
2017-08-16
4
M
0
2000
38.795
A
1031034
D
Common Stock
98000
I
by Ayers Family Trust
Non-Qualified Stock Option (right-to-buy)
38.795
2017-08-14
4
M
0
18000
D
2018-02-13
Common Stock
18000
307000
D
Non-Qualified Stock Option (right-to-buy)
38.795
2017-08-14
4
M
0
2000
D
2018-02-13
Common Stock
2000
305000
D
Non-Qualified Stock Option (right-to-buy)
38.795
2017-08-15
4
M
0
14900
D
2018-02-13
Common Stock
14900
290100
D
Non-Qualified Stock Option (right-to-buy)
38.795
2017-08-15
4
M
0
5100
D
2018-02-13
Common Stock
5100
285000
D
Non-Qualified Stock Option (right-to-buy)
38.795
2017-08-15
4
M
0
2000
D
2018-02-13
Common Stock
2000
283000
D
Non-Qualified Stock Option (right-to-buy)
38.795
2017-08-16
4
M
0
20000
D
2018-02-13
Common Stock
20000
263000
D
Non-Qualified Stock Option (right-to-buy)
38.795
2017-08-16
4
M
0
2000
D
2018-02-13
Common Stock
2000
261000
D
Represents the weighted average sales price of the shares sold ranging from a low of $154.80 to a high of $155.00 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Represents the weighted average sales price of the shares sold ranging from a low of $154.50 to a high of $154.95 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Represents the weighted average sales price of the shares sold ranging from a low of $154.25 to a high of $154.40 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Represents the weighted average sales price of the shares sold ranging from a low of $155.08 to a high of $156.025 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Grant of option to buy 200,000 shares of IDEXX Laboratories, Inc. common stock that became exercisable in five equal annual installments beginning on February 14, 2012 without giving effect to the 2-for-1 stock split of IDEXX Laboratories, Inc. common stock that occurred on June 15, 2015 (the "Stock Split"). The number of derivative securities reported as beneficially owned with respect to this option and its exercise price were adjusted to reflect the Stock Split.
Not applicable.
/s/ Lily J. Lu, Attorney-in-Fact for Jonathan W. Ayers
2017-08-16